Oxford Nanopore introduces new cDNA sequencing kits
Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Feb 19
Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology.
05 Feb 19
Ncardia, a provider of human iPSC-derived cell-based assays and services for drug discovery and development, announced today the…
31 Jan 19
Charles River Laboratories International and Toxys have agreed to offer access to ToxTracker assays suite in North America.
31 Jan 19
Magnolia Medical Technologies has secured $20m in Series C financing round to expand its Steripath platform and advance…
30 Jan 19
C2N Diagnostics, a company engaged in commercializing a suite of biomarker tests to enable early detection of debilitating…
29 Jan 19
PTS Diagnostics and Kroger Health, The Kroger Co.'s nationwide arm of health and wellness facilities, services and programs,…
29 Jan 19
Researchers at the School of Medicine have developed a highly sensitive urine test for diagnosing and monitoring bladder…
29 Jan 19
Global healthcare firm PHC Holdings has agreed to acquire anatomical pathology business from Thermo Fisher Scientific for around…
24 Jan 19
A researcher at Johns Hopkins University has developed what is claimed to be the first simple, affordable screening…
24 Jan 19
Medical technology firm Hologic has secured approval from the US Food and Drug Administration (FDA) for its Aptima…